3-46705887-C-T

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBS1_Supporting

The NM_147196.3(TMIE):​c.191C>T​(p.Ser64Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000366 in 1,614,130 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. S64S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00031 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00037 ( 1 hom. )

Consequence

TMIE
NM_147196.3 missense

Scores

11
8

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:1

Conservation

PhyloP100: 6.51

Publications

7 publications found
Variant links:
Genes affected
TMIE (HGNC:30800): (transmembrane inner ear) This gene encodes a transmembrane inner ear protein. Studies in mouse suggest that this gene is required for normal postnatal maturation of sensory hair cells in the cochlea, including correct development of stereocilia bundles. This gene is one of multiple genes responsible for recessive non-syndromic deafness (DFNB), also known as autosomal recessive nonsyndromic hearing loss (ARNSHL), the most common form of congenitally acquired inherited hearing impairment. [provided by RefSeq, Mar 2009]
TMIE Gene-Disease associations (from GenCC):
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal recessive nonsyndromic hearing loss 6
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.083521634).
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.000372 (544/1461786) while in subpopulation MID AF = 0.00711 (41/5768). AF 95% confidence interval is 0.00539. There are 1 homozygotes in GnomAdExome4. There are 290 alleles in the male GnomAdExome4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TMIENM_147196.3 linkc.191C>T p.Ser64Leu missense_variant Exon 2 of 4 ENST00000643606.3 NP_671729.2
TMIENM_001370524.1 linkc.32C>T p.Ser11Leu missense_variant Exon 2 of 4 NP_001357453.1
TMIENM_001370525.1 linkc.32C>T p.Ser11Leu missense_variant Exon 3 of 5 NP_001357454.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TMIEENST00000643606.3 linkc.191C>T p.Ser64Leu missense_variant Exon 2 of 4 NM_147196.3 ENSP00000494576.2
TMIEENST00000644830.1 linkc.32C>T p.Ser11Leu missense_variant Exon 2 of 4 ENSP00000495111.1
TMIEENST00000651652.1 linkc.89C>T p.Ser30Leu missense_variant Exon 1 of 2 ENSP00000498953.1

Frequencies

GnomAD3 genomes
AF:
0.000309
AC:
47
AN:
152226
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000393
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.000397
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000368
AC:
92
AN:
249670
AF XY:
0.000443
show subpopulations
Gnomad AFR exome
AF:
0.000193
Gnomad AMR exome
AF:
0.000550
Gnomad ASJ exome
AF:
0.000199
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000450
Gnomad OTH exome
AF:
0.00165
GnomAD4 exome
AF:
0.000372
AC:
544
AN:
1461786
Hom.:
1
Cov.:
32
AF XY:
0.000399
AC XY:
290
AN XY:
727204
show subpopulations
African (AFR)
AF:
0.000269
AC:
9
AN:
33480
American (AMR)
AF:
0.000470
AC:
21
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.000115
AC:
3
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000267
AC:
23
AN:
86250
European-Finnish (FIN)
AF:
0.0000562
AC:
3
AN:
53362
Middle Eastern (MID)
AF:
0.00711
AC:
41
AN:
5768
European-Non Finnish (NFE)
AF:
0.000371
AC:
412
AN:
1111984
Other (OTH)
AF:
0.000530
AC:
32
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
32
64
95
127
159
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000309
AC:
47
AN:
152344
Hom.:
0
Cov.:
33
AF XY:
0.000336
AC XY:
25
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.000168
AC:
7
AN:
41586
American (AMR)
AF:
0.000392
AC:
6
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5176
South Asian (SAS)
AF:
0.000621
AC:
3
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.000397
AC:
27
AN:
68038
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000416
Hom.:
0
Bravo
AF:
0.000283
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000234
AC:
2
ExAC
AF:
0.000379
AC:
46
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00104
EpiControl
AF:
0.000533

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:5Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:1
Apr 20, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 24875298) -

Mar 10, 2017
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 09, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 64 of the TMIE protein (p.Ser64Leu). This variant is present in population databases (rs189895472, gnomAD 0.06%). This missense change has been observed in individual(s) with deafness (PMID: 24875298). ClinVar contains an entry for this variant (Variation ID: 165460). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Autosomal recessive nonsyndromic hearing loss 6 Uncertain:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Mar 18, 2019
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The TMIE c.191C>T; p.Ser64Leu variant (rs189895472) was detected in a patient with recessive hereditary hearing loss in the heterozygous state; however, a likely causative variant in another gene was also identified (Vona 2014). This variant is listed in the genome Aggregation Database (gnomAD) with an overall population frequency of 0.04% (identified on 105 out of 281,070 chromosomes) and is classified as a variant of unknown significance in ClinVar (ID: 165460). The serine at position 64 is highly conserved, considering 12 species, and computational analyses of the effects of the p.Ser64Leu variant on protein structure and function make conflicting predictions (SIFT: tolerated, PolyPhen-2: possibly damaging). Based on the available information, the clinical significance of the p.Ser64Leu variant cannot be determined with certainty. -

not specified Uncertain:1
Sep 11, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant classified as Uncertain Significance - Favor Benign. The p.Ser64Leu vari ant in TMIE has been previously reported in the heterozygous state in four indiv iduals with hearing loss; however, an alternate explanation of the hearing loss was identified in two of these individuals (Vona 2014, LMM data). This variant h as been identified across several populations by the Exome Aggregation Consortiu m with a frequency of 0.04% (46/120742) of the total chromosomes (ExAC, http://e xac.broadinstitute.org; dbSNP rs189895472). However, its frequency is not high e nough to rule out a pathogenic role. Computational prediction tools and conserva tion analyses do not provide strong support for or against an impact to the prot ein. In summary, while the clinical significance of the p.Ser64Leu variant is un certain, the identification of the variant in several individuals with an altern ate explanation of the hearing loss suggests it is more likely benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.42
BayesDel_addAF
Benign
-0.085
T
BayesDel_noAF
Uncertain
-0.010
CADD
Pathogenic
27
DANN
Uncertain
0.99
DEOGEN2
Benign
0.30
.;T;T
Eigen
Uncertain
0.34
Eigen_PC
Uncertain
0.42
FATHMM_MKL
Uncertain
0.78
D
LIST_S2
Uncertain
0.95
D;.;D
M_CAP
Benign
0.076
D
MetaRNN
Benign
0.084
T;T;T
MetaSVM
Uncertain
0.31
D
MutationAssessor
Benign
0.83
.;L;L
PhyloP100
6.5
PrimateAI
Uncertain
0.75
T
PROVEAN
Benign
0.40
.;.;N
REVEL
Uncertain
0.48
Sift
Benign
0.50
.;.;T
Sift4G
Uncertain
0.041
.;.;D
Polyphen
0.99
.;D;D
Vest4
0.49
MVP
0.90
MPC
0.52
ClinPred
0.035
T
GERP RS
5.2
PromoterAI
-0.0053
Neutral
Varity_R
0.16
gMVP
0.81
Mutation Taster
=74/26
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs189895472; hg19: chr3-46747377; API